Literature DB >> 27063967

The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease research.

David C Fajgenbaum1, Jason R Ruth2, Dermot Kelleher3, Arthur H Rubenstein4.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27063967     DOI: 10.1016/S2352-3026(16)00007-7

Source DB:  PubMed          Journal:  Lancet Haematol        ISSN: 2352-3026            Impact factor:   18.959


× No keyword cloud information.
  18 in total

1.  International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum; Thomas S Uldrick; Adam Bagg; Dale Frank; David Wu; Gordan Srkalovic; David Simpson; Amy Y Liu; David Menke; Shanmuganathan Chandrakasan; Mary Jo Lechowicz; Raymond S M Wong; Sheila Pierson; Michele Paessler; Jean-François Rossi; Makoto Ide; Jason Ruth; Michael Croglio; Alexander Suarez; Vera Krymskaya; Amy Chadburn; Gisele Colleoni; Sunita Nasta; Raj Jayanthan; Christopher S Nabel; Corey Casper; Angela Dispenzieri; Alexander Fosså; Dermot Kelleher; Razelle Kurzrock; Peter Voorhees; Ahmet Dogan; Kazuyuki Yoshizaki; Frits van Rhee; Eric Oksenhendler; Elaine S Jaffe; Kojo S J Elenitoba-Johnson; Megan S Lim
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

Review 2.  Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 3.  TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.

Authors:  Gordan Srkalovic; Inga Marijanovic; Maya B Srkalovic; David C Fajgenbaum
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

Review 4.  Tissue chips - innovative tools for drug development and disease modeling.

Authors:  L A Low; D A Tagle
Journal:  Lab Chip       Date:  2017-09-12       Impact factor: 6.799

5.  How we manage idiopathic multicentric Castleman disease.

Authors:  Joshua D Brandstadter; David C Fajgenbaum
Journal:  Clin Adv Hematol Oncol       Date:  2022-09

Review 6.  A framework for fibrolamellar carcinoma research and clinical trials.

Authors:  Timothy A Dinh; Alan F Utria; Kevin C Barry; Rosanna Ma; Ghassan K Abou-Alfa; John D Gordan; Elizabeth M Jaffee; John D Scott; Jessica Zucman-Rossi; Allison F O'Neill; Mark E Furth; Praveen Sethupathy
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-02-21       Impact factor: 73.082

Review 7.  Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum
Journal:  Blood       Date:  2018-11-29       Impact factor: 22.113

8.  Importance of Participant-Centricity and Trust for a Sustainable Medical Information Commons.

Authors:  Amy L McGuire; Mary A Majumder; Angela G Villanueva; Jessica Bardill; Juli M Bollinger; Eric Boerwinkle; Tania Bubela; Patricia A Deverka; Barbara J Evans; Nanibaa' A Garrison; David Glazer; Melissa M Goldstein; Henry T Greely; Scott D Kahn; Bartha M Knoppers; Barbara A Koenig; J Mark Lambright; John E Mattison; Christopher O'Donnell; Arti K Rai; Laura L Rodriguez; Tania Simoncelli; Sharon F Terry; Adrian M Thorogood; Michael S Watson; John T Wilbanks; Robert Cook-Deegan
Journal:  J Law Med Ethics       Date:  2019-03       Impact factor: 1.718

9.  Tissue Chips to aid drug development and modeling for rare diseases.

Authors:  Lucie A Low; Danilo A Tagle
Journal:  Expert Opin Orphan Drugs       Date:  2016-10-19       Impact factor: 0.694

10.  International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.

Authors:  Frits van Rhee; Peter Voorhees; Angela Dispenzieri; Alexander Fosså; Gordan Srkalovic; Makoto Ide; Nikhil Munshi; Stephen Schey; Matthew Streetly; Sheila K Pierson; Helen L Partridge; Sudipto Mukherjee; Dustin Shilling; Katie Stone; Amy Greenway; Jason Ruth; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Raj Jayanthan; Elaine S Jaffe; Heather Leitch; Naveen Pemmaraju; Amy Chadburn; Megan S Lim; Kojo S Elenitoba-Johnson; Vera Krymskaya; Aaron Goodman; Christian Hoffmann; Pier Luigi Zinzani; Simone Ferrero; Louis Terriou; Yasuharu Sato; David Simpson; Raymond Wong; Jean-Francois Rossi; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Eric Oksenhendler; David C Fajgenbaum
Journal:  Blood       Date:  2018-09-04       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.